Veritas Investment Management’s Quest Diagnostics DGX Stock Holding History

Veritas Investment Management’s Portfolio DGX Stock Details DGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-1,300	Closed	-$122K	–	64
2017 Q3	$122K	Hold	1,300	–	–	0.02%	49
2017 Q2	$145K	Hold	1,300	–	–	0.02%	43
2017 Q1	$128K	Hold	1,300	–	–	0.02%	49
2016 Q4	$119K	Sell	1,300 -500	-28%	-$43.1K	0.02%	52
2016 Q3	$152K	Hold	1,800	–	–	0.03%	55
2016 Q2	$147K	Hold	1,800	–	–	0.03%	58
2016 Q1	$129K	Hold	1,800	–	–	0.03%	58
2015 Q4	$128K	Hold	1,800	–	–	0.02%	67
2015 Q3	$111K	Hold	1,800	–	–	0.03%	62
2015 Q2	$131K	Sell	1,800 -200	-10%	-$14.8K	0.04%	55
2015 Q1	$154K	Buy	+2,000	New	+$143K	0.05%	51
2014 Q4	–	Sell	-2,000	Closed	-$121K	–	38
2014 Q3	$121K	Hold	2,000	–	–	0.04%	57
2014 Q2	$117K	Hold	2,000	–	–	0.04%	67
2014 Q1	$116K	Hold	2,000	–	–	0.05%	62
2013 Q4	$107K	Hold	2,000	–	–	0.05%	57
2013 Q3	$123K	Hold	2,000	–	–	0.07%	50
2013 Q2	$121K	Buy	+2,000	New	+$119K	0.08%	41

Other funds holding DGX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return

Bessemer Group Woodbridge, New Jersey $63.6B AUM 28.76% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

FMI

Fiduciary Management Inc Milwaukee, Wisconsin $8.06B AUM 6.78% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Veritas Investment Management's DGX Position: Q4 2017 in Review

Veritas Investment Management sold out of Quest Diagnostics (DGX) in Q4 2017, closing a stake of 1,300 shares — an estimated $122K sold.

Veritas Investment Management first reported a position in DGX in Q2 2013 and held it in 17 quarters. The position peaked at $154K in Q1 2015. 631 funds tracked by Wall St. Rank hold DGX as of Q4 2017.

Veritas Investment Management reported no remaining Quest Diagnostics position as of Q4 2017 after selling out during the quarter.
Veritas Investment Management sold 1,300 Quest Diagnostics shares in Q4 2017, an estimated $122K.
Veritas Investment Management first reported a position in Quest Diagnostics in Q2 2013 and held it in 17 quarters.
Veritas Investment Management's Quest Diagnostics position peaked at $154K in Q1 2015.
631 funds tracked by Wall St. Rank held Quest Diagnostics as of Q4 2017.

Based on Veritas Investment Management's 13F filing for Q4 2017, filed 6 Feb 2018.